Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 38, 2003 - Issue 8
Submit an article Journal homepage
28
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Impact of Aging on the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection in Japan

Ohishi W. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Kitamoto M. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Aikata H. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Kamada K. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Kawakami Y. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Ishihara H. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Kamiyasu M. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Nakanishi T. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
,
Tazuma S. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
&
Chayama K. Dept. of Medicine and Molecular Science, Division of Frontier Medical Science Programs for Biomedical Research Graduate School of Biomedical Sciences Hiroshima University Hiroshima Japan
 show all
Pages 894-900 | Published online: 08 Jul 2009

  • Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-36.
  • Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor B, editors. Liver cancer. New York: Churchill Livingstone; 1997. p. 13-28.
  • Tang ZY. Hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15:G1-7.
  • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244: 359-62.
  • Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244: 362-4.
  • Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989;2:1004-6.
  • Colombo M, Kuo G, Choo QL, Donate MF, Del Ninno E, Tommasini MA, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2:1006-8.
  • Saite I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-9.
  • Hasan F, Jeffers LJ, Medina M, Reddy KR, Parker T, Schiff ER, et al. Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990; 12:589-91.
  • Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in Southern African blacks with hepatocellular carcinoma. Lancet 1990; 335:873-4.
  • Sbolli G, Zanetti AR, Tanzi E, Cavanna L, Civardi G, Fornari F, et al. Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. J Med Virol 1990; 30:230-2.
  • Vargas V, Castells L, Esteban JI. High frequency of antibodies to the hepatitis C virus among patients with hepatocellular carcinoma. Ann Intern Med 1990; 112:967.
  • Yu MC, Tong MJ, Coursaget P, Ross RK, Govindarajan S, Henderson BE. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82:1038-41.
  • Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, et al. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991; 12:367-71.
  • Nishioka K, Watanabe J, Furuta S, Tanaka E, lino S, Suzuki H, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-33.
  • Liang TJ, Jeffers LJ, Reddy KR, Medina M, Parker IT, Cheinquer H, et al. Viral Pathogenesis of hepatocellular carcinoma in the United States. Hepatology 1993; 18: 1326-33.
  • Okuda K. Heptatitis C virus and hepatocellular carcinoma. In: Okuda K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone; 1997. p. 39-50.
  • Haruna Y, Hayashi N, Kamada T, Hytiroglou P, Thung SN, Gerber MA. Expression of hepatitis C virus in hepatocellular carcinoma. Cancer 1994; 73:2253-8.
  • Kobayashi S, Hayashi H, Itoh Y, Asano T, Isono K. Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma. Cancer 1994; 73:48-52.
  • Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990; 211:277-87.
  • Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997; 350:1142-3.
  • Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998; 351:214-5.
  • EL-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340:745-50.
  • Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohiyohji F, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991; 51:2842-7.
  • Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328:1797-801.
  • Poynard T, Bedossa P, Opolon P. The OBSVIRC, METAVIR, CLINTVIR and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825-32.
  • Seeff LB. Natural history of hepatitis C. Am J Med 1999; 107: 10S-15S.
  • Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, et al. Long-term follow-up of post-transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10:69-76.
  • Di Bsceglle AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14:969-74.
  • Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Ribero ML, et al. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16:273-81.
  • Koretz L, Abbey H, Coleman E, Gitnick G. Non-A, non-B post-transfusion hepatitis: looking back in the second decade. Ann Intern Med 1993;! 19:110-5.
  • Friedman SL. Evaluation of fibrosis and hepatitis C. Am J Med 1999; 107:27S-30S.
  • Aizawa Y, Shibamoto Y, Takagi I, Zeniya M, Toda G. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. Cancer 2000; 89:53-9.
  • Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:47-53.
  • Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C, et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 2000;47: 131-6.
  • Moriya T, Koyama T, Tanaka J, Mishiro S, Yoshizawa H. Epidemiology of hepatitis C virus in Japan. Intervirology 1999; 42:153-8.
  • Sobin LH, Wittekind Ch, editors. International Union Against Cancer (UICC). TNM Classification of malignant tumours, 5th edn. New York: Wiley-Liss; 1997. p. 59-62.
  • Child CG, Turcotte JG. Surgery in portal hypertension. In: Child CG, editor. Major problems in clinical surgery: the liver and portal hypertension. Philadelphia: WB Saunders; 1964. p. 50.
  • World Health Organization. Hepatitis C: global prevalence. WkIy Epidemiol Rec 1997; 72:341-8.
  • Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999; 107:2S-9S.
  • Desenclos JC. Epidemiology of hepatitis C. Rev Prat 2000;50: 1066-70.
  • Yano M. Epidemiology of hepatitis C virus infection in Japan. Nippon Rinsho 1995; 53:346-50. In Japanese.
  • The Japan Society of Hepatology. The trend of hepatitis virus carrier. Kanganhakusyo; 1999. p. 23-32. In Japanese.
  • Tanaka J, Sasaki F, Nagakami H, Mizui M, Katayama K, Moriya T, et al. Incidence rate of HBV and HCV infection among voluntary blood donors in Hiroshima and Japan. Jap J Public Health 1997; 44:788-96. In Japanese.
  • Kusumi S, Tsuruta M, Akahoshi M, Kodama K, Moriya T, Sasaki F, et al. Seroepidemiological study of liver disease among atomic-bomb survivors. FY-1994 Report of A-bomb Disease Research Teams. Tokyo: Japan Public Health Association; 1995. p. 17-20. In Japanese.
  • Lemon SM. Hepatitis C: Current status and future directions for antiviral therapy. In: Okita K, editor. HCV and related liver diseases. Tokyo: Springer; 1999. p. 1-26.
  • Liver cancer study group of Japan. Survey and follow-up study of primary liver cancer in Japan: Report 14. Acta Hepatol Japonica 2000; 40:799-811.
  • Hamada H, Yatsuhashi H, Yano K, Daikoku M, Arisawa K, Inoue O, et al. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C. Cancer 2002; 95:331-9.
  • Benhamou Y, Bochet M, Martino V, Charlotte F, Azria F, Coutellier A, et al. Liver fibrosis progression in human immuno-deficiency vims and hepatitis C virus coinfected patients. Hepatology 1999;30:1054-8.
  • Garcia-Samaniego J, Rodriguez M, Berenguer J, Rodriguez-Rosado R, Carbo J, Asensi V, et al. Hepatocellular carcinoma in HTV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96:179-83.
  • Kiyosawa K, Sodeyama T, Tanaka B, Gibo Y, Yoshizawa K, Nakano Y, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12:671-5.
  • Yano M, Yatsuhashi H, Inoue O, Inokuchi K, Koga M. Epidemiology and long-term prognosis of hepatitis C virus infection in Japan. Gut 1993; 34:S13-6.
  • Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995;332: 1463-6.
  • Freeman AJ, Dore GJ, Law MG, Thorpe M, von Overbeck J, Lloyd AR, et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001; 34:809-16.
  • Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996; 23:1334-40.
  • Benson D, Mitchell N, Dix D. On the role of aging in carcinogenesis. Mutat Res 1996; 356:209-16.
  • Tarao K, Rino Y, Ohkawa S, Shimizu A, Tamai S, Miyakawa K, et al. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999; 86:589-95.
  • Tarao K, Rino Y, Ohkawa S, Tamai S, Miyakawa K, Takakura H, et al. Close association between high serum alanine aminotransferase levels and multicentric hepatocarcinogenesis in patients with hepatitis C virus-associated cirrhosis. Cancer 2002; 94:1787-95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.